Spikevax (previously COVID-19 Vaccine Moderna) Европейски съюз - български - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Ваксини - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Suvaxyn CSF Marker Европейски съюз - български - EMA (European Medicines Agency)

suvaxyn csf marker

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - Прасета - За активна имунизация на свинете с 7 седмична възраст и по-нататък, за да се предотврати смъртността и намаляване на инфекции и заболявания, причинени от вируса на класическата чума свинете (csfv). onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv. onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.

VidPrevtyn Beta Европейски съюз - български - EMA (European Medicines Agency)

vidprevtyn beta

sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - Ваксини - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 и 5. 1 in product information document). Използването на тази ваксина трябва да бъде приложена в съответствие с официалните препоръки.

Marcaine Spinal 5 mg/ml solution for injection България - български - Изпълнителна агенция по лекарствата

marcaine spinal 5 mg/ml solution for injection

astrazeneca uk ltd. - Бупивакаин - 5 mg/ml solution for injection

Marcaine Spinal Heavy 5 mg/ml solution for injection България - български - Изпълнителна агенция по лекарствата

marcaine spinal heavy 5 mg/ml solution for injection

astrazeneca uk ltd. - Бупивакаин - 5 mg/ml solution for injection

FLORON 40 mg/g premix for medicated feeding stuff for swine 40 mg/g България - български - БАБХ (Българска агенция по безопасност на храните)

floron 40 mg/g premix for medicated feeding stuff for swine 40 mg/g

krka - Флорфеникол - премикс за медикаментозен фураж - 40 mg/g - прасета

HYDRODOXX 500 mg/g powder for administration in drinking water for chickens and swine 500 mg/g България - български - БАБХ (Българска агенция по безопасност на храните)

hydrodoxx 500 mg/g powder for administration in drinking water for chickens and swine 500 mg/g

huvepharma nv - Доксициклин (като гиклат) - прах за прилагане с водата за пиене - 500 mg/g - пилета, свине

RIFEN 100 mg/ml solution for injection for horses, cattle and swine 100 mg/ml България - български - БАБХ (Българска агенция по безопасност на храните)

rifen 100 mg/ml solution for injection for horses, cattle and swine 100 mg/ml

vetviva richter ag - cetoprofen - инжекционен разтвор - 100 mg/ml - говеда, коне, свине

Comirnaty Европейски съюз - български - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Ваксини - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. Използването на тази ваксина трябва да бъде приложена в съответствие с официалните препоръки.

Meningococcal Polysaccharide Vaccine A + C powder and solvent for suspension for injection България - български - Изпълнителна агенция по лекарствата

meningococcal polysaccharide vaccine a + c powder and solvent for suspension for injection

sanofi pasteur s.a. - vaccinum meningitidis, посветен cerebrospinalis - powder and solvent for suspension for injection